News & Updates
Filter by Specialty:
Show Multimedia Only

GLP-1 RAs reduce depression, substance use in young patients with obesity, MASLD
17 Jun 2025
byStephen Padilla
In paediatric patients with obesity and metabolic dysfunction-associated steatotic liver disease (MASLD), treatment with GLP-1 receptor agonists (RAs) results in a decrease in depression and substance use, as shown in a study presented at ESPGHAN 2025.
GLP-1 RAs reduce depression, substance use in young patients with obesity, MASLD
17 Jun 2025
SGLT2i extends survival in amyloidosis patients with or without HF
16 Jun 2025
byStephen Padilla
Treatment with SGLT2 inhibitors can prolong the life of patients with amyloidosis with or without a diagnosis of heart failure (HF), a study has shown.
SGLT2i extends survival in amyloidosis patients with or without HF
16 Jun 2025
Vitamin D protective against BPPV
16 Jun 2025
byAudrey Abella
A group of researchers from Changi General Hospital in Singapore found lower rates of benign paroxysmal positional vertigo (BPPV) recurrence among older adults who supplemented their diet and Canalith Repositioning Procedure (CRP) with vitamin D.